vs

Side-by-side financial comparison of IRIDEX CORP (IRIX) and Lion Group Holding Ltd (LGHL). Click either name above to swap in a different company.

IRIDEX CORP is the larger business by last-quarter revenue ($14.7M vs $13.3M, roughly 1.1× Lion Group Holding Ltd).

IRIDEX Corporation is a global medical technology company that designs, manufactures and distributes advanced laser-based medical devices, primarily serving the ophthalmology and aesthetic medicine sectors. It supplies products to healthcare providers, clinics and medical facilities across North America, Europe, Asia Pacific and other regions, delivering minimally invasive solutions for eye disease treatment and cosmetic procedures.

LION is a Canadian electric vehicle manufacturer headquartered in Saint-Jérôme, Quebec. Founded in 2011 as Lion Bus, the company is primarily known for its production of yellow school buses, of which it was the first to mass produce as a fully electric vehicle.

IRIX vs LGHL — Head-to-Head

Bigger by revenue
IRIX
IRIX
1.1× larger
IRIX
$14.7M
$13.3M
LGHL

Income Statement — Q4 FY2025 vs Q2 FY2024

Metric
IRIX
IRIX
LGHL
LGHL
Revenue
$14.7M
$13.3M
Net Profit
$-53.7K
Gross Margin
37.2%
Operating Margin
Net Margin
-0.4%
Revenue YoY
-69.7%
Net Profit YoY
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRIX
IRIX
LGHL
LGHL
Q4 25
$14.7M
Q3 25
$12.5M
Q2 25
$13.6M
Q1 25
$11.9M
Q4 24
$12.7M
Q3 24
$11.6M
Q2 24
$12.6M
$13.3M
Q1 24
$11.8M
Net Profit
IRIX
IRIX
LGHL
LGHL
Q4 25
Q3 25
$-1.6M
Q2 25
$-994.0K
Q1 25
$-1.7M
Q4 24
$-834.0K
Q3 24
$-1.9M
Q2 24
$-2.7M
$-53.7K
Q1 24
$-3.5M
Gross Margin
IRIX
IRIX
LGHL
LGHL
Q4 25
37.2%
Q3 25
32.1%
Q2 25
34.5%
Q1 25
42.5%
Q4 24
44.0%
Q3 24
37.3%
Q2 24
40.7%
Q1 24
37.9%
Operating Margin
IRIX
IRIX
LGHL
LGHL
Q4 25
Q3 25
-11.3%
Q2 25
-6.9%
Q1 25
-1.7%
Q4 24
-3.9%
Q3 24
-16.1%
Q2 24
-20.9%
Q1 24
-28.0%
Net Margin
IRIX
IRIX
LGHL
LGHL
Q4 25
Q3 25
-12.6%
Q2 25
-7.3%
Q1 25
-14.2%
Q4 24
-6.6%
Q3 24
-16.7%
Q2 24
-21.2%
-0.4%
Q1 24
-29.5%
EPS (diluted)
IRIX
IRIX
LGHL
LGHL
Q4 25
Q3 25
$-0.09
Q2 25
$-0.06
Q1 25
$-0.10
Q4 24
$-0.05
Q3 24
$-0.12
Q2 24
$-0.16
Q1 24
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRIX
IRIX
LGHL
LGHL
Cash + ST InvestmentsLiquidity on hand
$6.0M
$29.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$28.4M
Total Assets
$29.2M
$74.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRIX
IRIX
LGHL
LGHL
Q4 25
$6.0M
Q3 25
$5.6M
Q2 25
$6.8M
Q1 25
$7.2M
Q4 24
$2.4M
Q3 24
$3.9M
Q2 24
$4.1M
$29.0M
Q1 24
$5.4M
Total Debt
IRIX
IRIX
LGHL
LGHL
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$1.0M
Q3 24
$1.4M
Q2 24
Q1 24
Stockholders' Equity
IRIX
IRIX
LGHL
LGHL
Q4 25
Q3 25
$4.7M
Q2 25
$6.1M
Q1 25
$852.0K
Q4 24
$2.1M
Q3 24
$2.6M
Q2 24
$4.2M
$28.4M
Q1 24
$6.5M
Total Assets
IRIX
IRIX
LGHL
LGHL
Q4 25
$29.2M
Q3 25
$28.4M
Q2 25
$31.6M
Q1 25
$34.2M
Q4 24
$29.1M
Q3 24
$30.2M
Q2 24
$31.2M
$74.5M
Q1 24
$34.1M
Debt / Equity
IRIX
IRIX
LGHL
LGHL
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.48×
Q3 24
0.53×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IRIX
IRIX

Segment breakdown not available.

LGHL
LGHL

Trading gains$7.8M59%
Other$2.4M18%
Securities brokerage commissions and fees$1.7M13%
Market making commissions and fees$1.0M8%
Other income$380.2K3%

Related Comparisons